Sorrento Therapeutics Inc. shareholders lack grounds to appeal a bankruptcy court’s decision blocking a broad probe into whether company attorneys sought to exploit a romantic relationship involving ...

As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promising clinical efficacy, durable responses, and growing ...

Equities researchers at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued on Sunday. The firm set a “hold” rating on the ...

DARZALEX has significant market potential as a leading monoclonal antibody for multiple myeloma treatment. Its approval in various combinations for both newly diagnosed and relapsed/refractory ...

In 2012, Ohio revamped its dog laws to move away from restrictions targeted at specific types of dogs, such as pit bulls. The current law focuses on the behavior of the dogs, not the breeds.

Shares of TNYA stock opened at $0.70 on Wednesday. The company has a market capitalization of $55.37 million, a P/E ratio of -0.49 and a beta of 2.83. Tenaya Therapeutics has a fifty-two week low ...

US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly ...

In this article, we are going to take a look at where Viking Therapeutics Inc. (NASDAQ:VKTX) stands against other stocks that are skyrocketing today. The stock market ended mixed on Wednesday ...

US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly, any ...

Viking Therapeutics' stock declined by 37% following a downgrade to "hold" in December, anticipating competitive pressures from Novo Nordisk's CagriSema Phase 3 results. The company's GIP/GLP-1 ...